TOTAL VASCULAR EXCLUSION FOR MAJOR HEPATECTOMY IN PATIENTS WITH ABNORMAL LIVER PARENCHYMA

Citation
J. Emond et al., TOTAL VASCULAR EXCLUSION FOR MAJOR HEPATECTOMY IN PATIENTS WITH ABNORMAL LIVER PARENCHYMA, Archives of surgery, 130(8), 1995, pp. 824-831
Citations number
41
Categorie Soggetti
Surgery
Journal title
ISSN journal
00040010
Volume
130
Issue
8
Year of publication
1995
Pages
824 - 831
Database
ISI
SICI code
0004-0010(1995)130:8<824:TVEFMH>2.0.ZU;2-O
Abstract
Background: Total vascular exclusion (TVE) of the liver has been used to increase the safety of hepatectomy and the feasibility of difficult resections. Until recently, however, concern about the detrimental ef fect of warm ischemia has limited the use of this technique to patient s with normal liver parenchyma. Objective: To compare surgical outcome s of 12 patients with abnormal livers (group 1) with outcomes of 48 pa tients with normal parenchyma (group 2), based on the hypothesis that uncontrolled bleeding may be more detrimental than planned hepatic isc hemia. Design and Setting: Retrospective analysis of 60 consecutive pa tients undergoing liver resection under TVE in a university medical ce nter. Patients: All 10 patients with cirrhosis had albumin levels of 3 0 g/L or higher and normal prothrombin times preoperatively; none had ascites. Two patients with cholestasis (one with cholangiocarcinoma an d one with hepatocellular carcinoma) are included in group 1. Interven tion: All 12 group 1 patients and 44 of 48 group 2 patients underwent total or extended lobectomy, with TVE induced by clamping the hilum an d the vena cava above and below the liver during parenchyma division. Main Outcome Measures: Hospital survival and selected surgical and lab oratory parameters. Results: Operative times, ischemic times, and bloo d loss (1975+/-1601 vs 1255+/-1291 mL) (P=.10) were comparable in both groups. Sixty-day operative mortality was zero in both groups. There was an increased rate of complications in group 1 (44% vs 17% [P=.06]) . Transient abnormal liver function was observed in both groups. Howev er, significant delay in restoration of normal function was observed i n group 1 with respect to bilirubin levels and prothrombin time. Concl usions: Patients with cirrhosis can undergo successful resection using TVE. This conclusion must be limited to cirrhotic patients with good liver function. The trend toward increased blood loss may reflect grea ter difficulties in establishing hemostasis after reperfusion in group 1. While this group appears to have a higher risk for hepatic insuffi ciency, successful outcomes were achieved in all cases. Prospective st udy will be required to define the parameters for use of TVE in cirrho sis.